Addressing the Challenges of Complex Analytes and Matrices in Preparation for Routine Sample Analysis

October 23, 2020
KCAS Bioanalytical and Biomarker Services

Webcast

***Live: Tuesday November 10, 2020 at 11am EST| 8am PST| 4pm CET| 5pm CET***Sometimes in bioanalysis, solving the fundamental challenge of developing an assay isn’t enough. The webcast will review strategies for solving scientifically challenging problems and providing assays that are robust and reproducible during routine sample analysis.*** On demand available after final airing until Nov. 10, 2021.***

Register free: https://www.pharmtech.com/pt_w/addressing_challenges

Event Overview: Bioanalytical liquid chromatography­–mass spectrometry (LC–MS) for small molecules is often referred to as a routine technology. That perception may be true for many drugs, but as pharmaceutical companies move into new areas, more projects may present challenges in at least part of their scope, such as drug moiety, the matrices being assessed, the need for biomarker assessment, or high sensitivity requirements.

The challenge for bioanalytical service providers is to develop LC-MS assays to address these challenges and provide resulting methods that are robust and reliable enough to allow hand off to additional teams to support extensive sample analysis.

Key Learning Objectives:

  • Develop knowledge of the factors that present analytical challenges when developing bioanalytical methodologies
  • Gain insight into strategies for dealing with challenging analytes, matrices, and assay limitations
  • Review case studies presenting experiences with solving challenging LC-MS/MS assays and translating the solution to a production

Speaker: John Perkins, PhD, Senior Scientific Officer, KCAS

Time and Date: Tuesday November 10, 2020 at 11am EST| 8am PST| 4pm CET| 5pm CET

On demand available after final airing until Nov. 10, 2021

Sponsor: KCAS

Register free:https://www.pharmtech.com/pt_w/addressing_challenges

Related Content:

Webcasts